港A兩地特斯拉概念股走強 上海超級工廠有望刷新“特斯拉速度”
格隆匯5月19日丨港A兩地特斯拉概念股走強,耐世特(1316.HK)漲9.39%、福耀玻璃(3606.HK)漲5.08%;A股文燦股份、宜安科技漲停,京威股份、風華高科漲逾4%。斯拉中國副總裁陶琳表示,來自中國的抗疫經驗正輸出到美國,成為剛剛復工的美國工廠借鑑的樣板。特斯拉上海超級工廠也是中國復工復產最早的汽車製造工廠之一。工廠目前正順利生產,預計今年6月就可實現周生產4000輛的目標,這意味着實際產量將超過一期超級工廠年產15萬台的設計產能。超級工廠二期進展也非常順利,預計今年底將完成建設,明年一季度有望實現Model Y車型量產。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.